Jeff Etter

Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter, Robert Tjin Tham Sjin, Henry J. Haringsma et al. · Cancer Discovery · 2013 · 627 citations · Full text

Medicine, Oncology, Pharmacology +17

<i>In Vitro</i> and <i>In Vivo</i> Characterization of Irreversible Mutant-Selective EGFR Inhibitors That Are Wild-Type Sparing

Robert Tjin Tham Sjin, Kwangho Lee, Annette O. Walter et al. · Molecular Cancer Therapeutics · 2014 · 70 citations

Medicine, Oncology, Pharmacology +14

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors

Mingxiang Liao, Simon P. Watkins, Eileen Nash et al. · Investigational New Drugs · 2019 · 35 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Identification of a Nickel(II) Binding Site on Hemoglobin Which Confers Susceptibility to Oxidative Deamination and Intramolecular Cross-linking

Joseph Levine, Michael J. Weickert, Maria Pagratis et al. · Journal of Biological Chemistry · 1998 · 22 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Nickel-catalyzed N-terminal Oxidative Deamination in Peptides Containing Histidine at Position 2 Coupled with Sulfite Oxidation

Joseph Levine, Jeff Etter, Izydor Apostoł · Journal of Biological Chemistry · 1999 · 11 citations · Full text

Natural Sciences, Biochemistry, Chemistry +14